Mesoblast Limited - PE Ratio

The PE Ratio as of October 2026 (TTM) for Mesoblast Limited (MSB.AX) is -13.21

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current PE Ratio is -13.21. This represents a change of -67.13% compared to the average of -40.19 of the last 4 quarters.

Mesoblast Limited (MSB.AX) Historical PE Ratio (quarterly & annually)

How has MSB.AX PE Ratio performed in the past?

The mean historical PE Ratio of Mesoblast Limited over the last ten years is -11.50. The current -13.21 PE Ratio has changed 11.39% with respect to the historical average. Over the past ten years (40 quarters), MSB.AX's PE Ratio was at its highest in in the December 2017 quarter at 9.32. The PE Ratio was at its lowest in in the March 2026 quarter at -55.61.

Mesoblast Limited (MSB.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mesoblast Limited (MSB.AX) Average PE Ratio

How has MSB.AX PE Ratio performed in the past?

The current PE Ratio of Mesoblast Limited (MSB.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mesoblast Limited (MSB.AX) PE Ratio vs. Peers

How is MSB.AX’s PE Ratio compared to its peers?

Mesoblast Limited’s PE Ratio is less than Neuren Pharmaceuticals Limited (127.61), less than Clarity Pharmaceuticals Ltd (-6.97), less than Summerset Group Holdings Limited (5.56), greater than PYC Therapeutics Limited (-45.35), less than Dimerix Limited (-4.63), greater than Starpharma Holdings Limited (-47.66), less than Island Pharmaceuticals Limited (-10.14), less than Immutep Limited (-0.58), less than NeuroScientific Biopharmaceuticals Limited (-4.46), less than Cynata Therapeutics Limited (-0.29),

Build a custom stock screener for Mesoblast Limited (MSB.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MSB.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.